Skip to main content
logo
Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.8250
+0.0243 (3.03%)
At close: Oct 5, 2026, 4:00 PM EDT
0.8224
-0.0026 (-0.32%)
After-hours: Oct 5, 2026, 7:31 PM EDT

Rein Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-49.76-49.87-62.88-15.73-27.33-26.16
Depreciation & Amortization
-00.060.120.170.12
Other Amortization
1.08-----
Loss (Gain) From Sale of Assets
----0.04--0.07
Asset Writedown & Restructuring Costs
28.728.737---
Loss (Gain) From Sale of Investments
---0.03-0.210.24
Stock-Based Compensation
2.022.221.121.192.082.26
Other Operating Activities
0.870.45----0.39
Change in Accounts Payable
-1.653.07-0.28-4.980.51-0.39
Change in Other Net Operating Assets
0.63-3.224.25-0.4-0.090.63
Operating Cash Flow
-18.83-19.36-22.29-19.81-24.87-23.75
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
------0.16
Sale of Property, Plant & Equipment
---0.04-0.07
Cash Acquisitions
----0.1--
Investment in Securities
-35.07--16.2526.46-35.83
Investing Cash Flow
-35.07--16.226.46-35.92

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---15.79--
Net Debt Issued (Repaid)
-1.08--15.79--
Issuance of Common Stock
553.4410.79--59.16
Other Financing Activities
2.856.327.03---3.51
Financing Cash Flow
56.779.7617.8215.79-55.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.05-0.04--0.06--
Net Cash Flow
2.82-9.65-4.4712.121.59-4.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.83-19.36-22.29-19.81-24.87-23.91
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.22-0.76-1.24-4.31-5.48-5.38
Levered Free Cash Flow
-7.79-11.37-14.82-7.62-14.48-13.5
Unlevered Free Cash Flow
-8.86-11.37-14.82-7.62-14.48-13.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-1.74-0.872.41-5.380.420.24
SEC Filings: 10-K · 10-Q